Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

4.27
BATS BZX Real-Time Price
As of 1:41pm ET
 -0.19 / -4.26%
Today’s Change
3.46
Today|||52-Week Range
10.08
-18.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company's product AFREZZA inhalation powder, which is an ultra rapid-acting insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Valencia, CA.

Contact Information

MannKind Corp.
28903 North Avenue Paine
Valencia California 91355
P:(661) 775-5300
Investor Relations:
(661) 295-4784

Employees

Shareholders

Individual stakeholders37.52%
Mutual fund holders14.85%
Other institutional11.22%

Top Executives

Hakan S. EdstromPresident, Chief Executive Officer & Director
Juergen A. MartensChief Operating Officer & Chief Technology Officer
Matthew J. PfefferCFO, Vice President & Head-Investor Relations
David B. ThomsonSecretary, Vice President & General Counsel
Robert A. BaughmanSenior Vice President-Clinical Sciences